Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases

Area of Science:

• Endocrinology
• Rheumatology
• Immunology

Background:

• Autoimmune polyendocrine syndromes (APSs) are characterized by autoimmune-mediated dysfunction of at least two endocrine glands.
• These syndromes develop in genetically susceptible individuals due to environmental triggers.
• APSs frequently co-occur with autoimmune rheumatic diseases, potentially exacerbating their clinical course.

Purpose of the Study:

• To highlight the clinical significance of APSs, particularly APS-2 and APS-3.
• To emphasize the impact of undiagnosed endocrinopathies on rheumatic disease management and patient prognosis.
• To underscore the importance of comprehensive patient evaluation for early detection and intervention.

Main Methods:

• Review of existing literature on Autoimmune Polyendocrine Syndromes.
• Analysis of the co-occurrence of APSs with specific rheumatic diseases like rheumatoid arthritis, systemic lupus erythematosus, and Sjögren's syndrome.
• Emphasis on clinical interview and physical examination findings for identifying potential endocrinopathies and other autoimmune markers.

Main Results:

• APS-2 and APS-3 are the most common forms, often involving Hashimoto's disease, celiac disease, rheumatoid arthritis, type 1 diabetes, and hypogonadism.
• Undiagnosed endocrine issues can worsen metabolic disturbances, hinder rheumatological treatment efficacy, and increase risks of osteoporosis, cardiovascular events, and pregnancy loss.
• Clinical presentation may include symptoms of endocrinopathy and signs of other autoimmune conditions like vitiligo.

Conclusions:

• Early recognition of APSs is vital for effective management of associated rheumatic and endocrine conditions.
• Thorough patient history and physical examination are essential for screening and diagnosing APSs.
• Integrated care approaches are necessary to address the complex interplay between autoimmune endocrine and rheumatic diseases.